BRAF G469X
Gene Variant Detail

Request Content

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

Gene BRAF
Variant G469X
Impact List missense
Protein Effect unknown
Gene Variant Descriptions BRAF G469X indicates any BRAF missense mutation that results in replacement of the glycine (G) at amino acid 469 by a different amino acid.
Associated Drug Resistance
Category Variants Paths

BRAF mutant BRAF G469X

Filtering

  • Case insensitive filtering will display rows if any text in any cell matches the filter term
  • Use simple literal full or partial string matches
  • Separate multiple filter terms with a space. Any order may be used (i. e. a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page. Filtering has no impact on query parameters.
  • Use quotes to match on a longer phrase with spaces (i.e. "mtor c1483f")

Sorting

  • Generally, the default sort order for tables is set to be first column ascending; however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column. Be sure to set ascending or descending order for a given column before moving on to the next column.

Transcript NM_004333.6
gDNA chr7:g.140781601_140781603
cDNA c.1405_1407
Protein p.G469
Source Database RefSeq
Genome Build GRCh38/hg38
Transcript gDNA cDNA Protein Source Database Genome Build
NM_004333.6 chr7:g.140781601_140781603 c.1405_1407 p.G469 RefSeq GRCh38/hg38
NM_001378470.1 chr7:g.140777999_140778001 c.1405_1407 p.G469 RefSeq GRCh38/hg38
NM_001354609.1 chr7:g.140781601_140781603 c.1405_1407 p.G469 RefSeq GRCh38/hg38
NM_004333.5 chr7:g.140781601_140781603 c.1405_1407 p.G469 RefSeq GRCh38/hg38
NM_001378474.1 chr7:g.140781601_140781603 c.1405_1407 p.G469 RefSeq GRCh38/hg38
NM_001378468.1 chr7:g.140781601_140781603 c.1405_1407 p.G469 RefSeq GRCh38/hg38
NM_001378467.1 chr7:g.140781610_140781612 c.1405_1407 p.G469 RefSeq GRCh38/hg38
XM_047420769.1 chr7:g.140781601_140781603 c.1405_1407 p.G469 RefSeq GRCh38/hg38
NM_001354609.2 chr7:g.140781601_140781603 c.1405_1407 p.G469 RefSeq GRCh38/hg38

Filtering

  • Case insensitive filtering will display rows if any text in any cell matches the filter term
  • Use simple literal full or partial string matches
  • Separate multiple filter terms with a space. Any order may be used (i. e. a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page. Filtering has no impact on query parameters.
  • Use quotes to match on a longer phrase with spaces (i.e. "mtor c1483f")

Sorting

  • Generally, the default sort order for tables is set to be first column ascending; however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column. Be sure to set ascending or descending order for a given column before moving on to the next column.

Clinical Trial Phase Therapies Title Recruitment Status Covered Countries Other Countries
NCT04488003 Phase II Ulixertinib Study of Ulixertinib for Patients With Advanced Malignancies Harboring MEK or Atypical BRAF Alterations Terminated USA 0
NCT03839342 Phase II Binimetinib + Encorafenib Binimetinib and Encorafenib for the Treatment of Advanced Solid Tumors With Non-V600E BRAF Mutations (BEAVER) Active, not recruiting CAN 0